Publication|Videos|May 2, 2024
Waters Introduces the Next Generation of HPLC for Biopharmaceutical Separations
Author(s)Waters Corporation
Fraser McLeod (VP, General Manager QA/QC, Waters Corporation) goes in depth about Waters' newest HPLC launch.
Sponsored by Waters Corporation
Fraser McLeod sat down with LCGC to discuss the latest HPLC system as well as where Waters is headed for the future.
Learn more about:
- The Alliance iS Bio HPLC System, the new instrument in the Alliance iS HPLC family, designed for biopharma QC labs.
- The impact of the new system on biopharma customers, and on the broader biopharma QC market.
- Where the future of LC is heading at Waters.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
